Assessment of monocytic-myeloid-derived suppressive cells (M-MDSC) before and after allogeneic hematopoietic stem cell transplantation in acute leukemia patients.

EJHaem · 2023 · PMC10660606 · PMID 38024608

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

a nonsignificant trendp = 0.10so close (0.05 < p ≤ 0.1)

Finally, considering only AML patients ( n = 47), higher M‐MDSC levels were associated with a higher risk of relapse, confirmed in multivariate analysis (HR: 4.30 [95%CI: 1.20–15.48], p = 0.025; Figure 3A ), while there was a nonsignificant trend for lower DFS (3‐year DFS: 33% vs. 65%, p = 0.10; Figure 3B ). 3.3.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.